RxDoctor Payments Data

Tomoyoshi Shigematsu

Neurological Surgery · New York, NYNPI 1093259368

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Imperative Care, Inc at 52.6% of the total. Reporting peaked in 2023 at $11,078 and has fallen 69.7% since, to $3,359 in 2025.

$21,552in general payments, 2019–2025

Across 88 payments — averaging $244.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Imperative Care, Inc$11K
  • Asahi Intecc CO., LTD.$2K
  • Kaneka Medical America LLC$2K
  • Microvention, Inc.$2K
  • Stryker$2K
  • Asahi Intecc USA, Inc.$516
  • plus $1K from 10 others
$125,528in research payments, 2019–2025

Across 31 payments — averaging $4049.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$126K

What the payments were for

  • Consulting fees$3,81118%
  • Travel & lodging$10,06047%
  • Food & beverage$7,14333%
  • Entertainment$5382%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,552 in reported general payments places this provider in the 75th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024
$100,715
Medicare patients
105
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →